Gliomatosis peritonei. Report of two cases and review of literature.
Gliomatosis peritonei, a rare complication of solid ovarian teratomas, is a miliary, mature glial implantation on the peritoneum or omentum. Two new cases are reported and 30 previously reported cases are reviewed. Gliomatosis peritonei is thought to be benign in almost all cases and thus deserves no treatment except for confirmatory biopsy. It must be differentiated from teratomatous implants because the latter may imply poor prognosis and require aggressive therapy. The prognostic value of serum alpha-fetoprotein levels in patients with immature ovarian teratoma is not conclusive. The presence of glial fibrillary acidic protein confirms the glial nature of the implants.
D000293:Adolescent; D002648:Child; D005260:Female; D005904:Glial Fibrillary Acidic Protein; D005910:Glioma / Q000175:diagnosis / Q000473:pathology*; D006801:Humans; D007124:Immunoenzyme Techniques; D007381:Intermediate Filament Proteins / Q000032:analysis; D009378:Neoplasms, Multiple Primary / Q000175:diagnosis / Q000473:pathology*; D010051:Ovarian Neoplasms / Q000473:pathology* / Q000601:surgery; D010534:Peritoneal Neoplasms / Q000175:diagnosis / Q000473:pathology*; D013724:Teratoma / Q000473:pathology* / Q000601:surgery
D005904:Glial Fibrillary Acidic Protein; D007381:Intermediate Filament Proteins